N

NKMax Co Ltd
KOSDAQ:182400

Watchlist Manager
NKMax Co Ltd
KOSDAQ:182400
Watchlist
Price: 2 020 KRW 9.54% Market Closed
Market Cap: 172.7B KRW

Operating Margin

42%
Current
Improving
by 283.8%
vs 3-y average of -241.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
42%
=
Operating Income
₩3.3B
/
Revenue
₩7.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
42%
=
Operating Income
₩3.3B
/
Revenue
₩7.9B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
NKMax Co Ltd
KOSDAQ:182400
172.7B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
378.8B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.8B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
85.6B AUD
Loading...
NL
argenx SE
XBRU:ARGX
40.7B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
No Stocks Found

Market Distribution

Higher than 96% of companies in Korea
Percentile
96th
Based on 2 615 companies
96th percentile
42%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

NKMax Co Ltd
Glance View

Market Cap
172.7B KRW
Industry
Biotechnology

NKMAX Co., Ltd. engages in the development, manufacture, and sale of recombinant proteins and monoclonal antibodies. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2015-10-23. The firm is involved in the production and sale of recombinant proteins, monoclonal antibodies, NK cell activity test kits, cell therapy products, and in the provision of other related services. The NK cell activity test kits are provided under the name of NK Vue. The firm distributes its products within domestic market and to overseas markets.

NKMax Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
42%
=
Operating Income
₩3.3B
/
Revenue
₩7.9B
What is NKMax Co Ltd's current Operating Margin?

The current Operating Margin for NKMax Co Ltd is 42%, which is above its 3-year median of -241.8%.

How has Operating Margin changed over time?

Over the last 3 years, NKMax Co Ltd’s Operating Margin has increased from -438.8% to 42%. During this period, it reached a low of -625.2% on Dec 31, 2023 and a high of 286.4% on Mar 31, 2024.

Back to Top